Department of Cardiology, Institute of Cardiovascular Research, Xinqiao Hospital, Army Medical University, Chongqing, China.
Biomark Med. 2023 Jan;17(1):29-39. doi: 10.2217/bmm-2022-0548. Epub 2023 Mar 30.
The study sought to investigate the association of non-high-density-lipoprotein cholesterol-to-high-density-lipoprotein cholesterol ratio (NON-HDL-C:HDL-C) with coronary lesions and major adverse cardiovascular events (MACE) in first-onset non-ST-segment elevation acute myocardial infarction. A cohort of 426 patients undergoing early invasive therapy was enrolled in the final analysis. MACE included cardiac death, nonfatal myocardial infarction, target vessel revascularization, congestive heart failure and nonfatal stroke. NON-HDL-C:HDL-C revealed a powerful diagnostic performance for multiple cardiovascular risk factors (p < 0.05). NON-HDL-C:HDL-C was an independent predictor for severe coronary lesions and MACE (p < 0.05). Subgroup analysis further examined the robustness, especially in elderly, male, dyslipidemic or nondiabetic patients. NON-HDL-C:HDL-C is associated with coronary lesions and prognosis in non-ST-segment elevation acute myocardial infarction.
本研究旨在探讨非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NON-HDL-C:HDL-C)与首发非 ST 段抬高型急性心肌梗死患者冠状动脉病变和主要不良心血管事件(MACE)的关系。最终分析纳入了 426 例接受早期有创治疗的患者。MACE 包括心脏死亡、非致死性心肌梗死、靶血管血运重建、充血性心力衰竭和非致死性卒中。NON-HDL-C:HDL-C 对多种心血管危险因素具有较强的诊断性能(p<0.05)。NON-HDL-C:HDL-C 是严重冠状动脉病变和 MACE 的独立预测因子(p<0.05)。亚组分析进一步检验了其稳健性,特别是在老年、男性、血脂异常或非糖尿病患者中。NON-HDL-C:HDL-C 与非 ST 段抬高型急性心肌梗死患者的冠状动脉病变和预后相关。